Sex differences in the percentage of IRF5 positive B cells are associated with higher production of TNF-α in women in response to TLR9 in humans

The clinical course and outcome of many diseases differ between women and men, with women experiencing a higher prevalence and more severe pathogenesis of autoimmune diseases. The precise mechanisms underlying these sex differences still remain to be fully understood. IRF5 is a master transcription...

Full description

Saved in:
Bibliographic Details
Main Authors: Beisel, Claudia (Author) , Jordan-Paiz, Ana (Author) , Köllmann, Sandra (Author) , Ahrenstorf, Annika Elise (Author) , Padoan, Benedetta (Author) , Barkhausen, Tanja (Author) , Addo, Marylyn M. (Author) , Altfeld, Marcus (Author)
Format: Article (Journal)
Language:English
Published: 22 February 2023
In: Biology of sex differences
Year: 2023, Volume: 14, Pages: 1-11
ISSN:2042-6410
DOI:10.1186/s13293-023-00495-x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13293-023-00495-x
Get full text
Author Notes:Claudia Beisel, Ana Jordan-Paiz, Sandra Köllmann, Annika Elise Ahrenstorf, Benedetta Padoan, Tanja Barkhausen, Marylyn M. Addo and Marcus Altfeld
Description
Summary:The clinical course and outcome of many diseases differ between women and men, with women experiencing a higher prevalence and more severe pathogenesis of autoimmune diseases. The precise mechanisms underlying these sex differences still remain to be fully understood. IRF5 is a master transcription factor that regulates TLR/MyD88-mediated responses to pathogen-associated molecular patterns (PAMPS) in DCs and B cells. B cells are central effector cells involved in autoimmune diseases via the production of antibodies and pro-inflammatory cytokines as well as mediating T cell help. Dysregulation of IRF5 expression has been reported in autoimmune diseases, including systemic lupus erythematosus, primary Sjögren syndrome, and rheumatoid arthritis.
Item Description:Gesehen am 29.03.2023
Physical Description:Online Resource
ISSN:2042-6410
DOI:10.1186/s13293-023-00495-x